|
|
|
|
E-Prescribing Vendors Talk Back
Digital HealthCare & Productivity | A month ago, acting Centers for Medicare and Medicaid Services (CMS) administrator Kerry Weems said that physicians can no longer use cost as an excuse for not switching to electronic prescribing. “The business case is turned around,” Weems said citing the affordability of the technology and reasonably small workflow changes it requires.
|
|
MGMA Meeting Pushes High Tech Patient ID Cards
Digital HealthCare & Productivity | SAN DIEGO—The Medical Group Management Association (MGMA) will push the health insurance industry to standardize patient identification cards with magnetic stripes, bar codes, or embedded chips and has commissioned a study to quantify the potential savings for payers and providers alike.
|
|
e-Prescribing Crash Course
Digital HealthCare & Productivity | Acting Centers for Medicare and Medicaid Services (CMS) administrator Kerry Weems called last week’s national conference on electronic prescribing a “crash course in e-prescribing.” The Oct. 7 event brought more than 1,400 physicians, pharmacists, practice administrators, health-IT professionals, vendors, and government representatives to Boston for an intensive study of the technology ahead of a Medicare incentive program that begins in January.
|
|
CMS Focuses on E-Prescribing
Digital HealthCare & Productivity | BOSTON—With less than three months to go before Medicare starts paying incentives to physicians for electronic prescribing, the Centers for Medicare and Medicaid Services (CMS) is working frantically to get the word out about the benefits of such technology.
|
|
Affordable DNA Sequencing, Improved Imaging Technologies, Move the PM Ball Forward
Digital HealthCare & Productivity | Slashing the cost of DNA sequencing is a prerequisite to making genomic medicine widely available and early this week, a new contender—Complete Genomics—emerged with a pledge to hit the $1000 genome price perhaps by this spring. My colleague and Bio-IT World’s editor-in-chief, Kevin Davies, was one the journalists to receive a comprehensive briefing and has charted the new company’s ambitious plans in an article posted online.
|
|
McKesson’s Personalized Medicine Prospects
Digital HealthCare & Productivity | McKesson is jockeying for a prominent position in the rapidly evolving personalized medicine race, developing capabilities for next-generation electronic health records (EHRs), says Andrew Mellin, vice president for Predictive Care Solutions. The San Francisco-based health care giant formed this new group last year within the Life Sciences division, focusing in particular on tweaking its Horizon Clinicals products—decision support and physician order entry—to support advancements in genomics, genetic testing, and bioinformatics as they emerge.
|
|
MediNotes Acquisition to Open Doors to Physician Practices
Digital HealthCare & Productivity | With its recently announced plans to take over MediNotes (West Des Moines, Iowa), Atlanta-based hospital systems vendor Eclipsys is making a push into the fast-growing but hard-to-reach market for independent physician practices
|
|
Global Image Search
Digital HealthCare & Productivity | It’s certainly not the first Web site to be likened to YouTube for medicine, but Medting.com—formerly called MDPIXX—might just be the first truly global online repository of medical images and multimedia for physicians. The site, developed in Spain, also includes platforms for clinical exchange and telemedicine.
|
|
Survey Says Epocrates Enjoys iPhone Success
Digital HealthCare & Productivity | If the iPhone is the killer app that pushes thousands of physicians to adopt health-IT (see “iPhone Will Change Health-IT, Says Datamonitor”), then the Epocrates Rx drug and formulary reference might be the software equivalent. At least that’s what San Mateo, Calif.-based Epocrates is claiming, based on the results of a customer survey.
|
|
Cancer Biomarkers Make Progress, Present Challenges
Digital HealthCare & Productivity | The rush to develop effective biomarkers has perhaps been greatest in cancer and there have been notable successes. Clearly the need is great, but solid progress has also been accompanied by scientific and business model challenges
|
Turning Genomics Data into Practical Insight With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can: - Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines.
- Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image).
Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands.
New Complimentary Market Survey… Collaborations and Communications Within Drug Discovery Research This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns. An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide
Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:
- Current practices in clinical trial logistics
- Comparing advances in clinical supply practices to other aspects of clinical trials
- Where current practices fall short of meeting the challenges
- Trends and evolving improvements that may change the way logistics are conducted
Listen Now
More Podcasts
Scientific Software Engineer
Boston MA
$70,000 to $95,000
Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET.
Apply at http://jobs.tessella.com
Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes. As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers. This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions. It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply
Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules. It is therefore suitable for use in a variety of markets including scientific research and clinical applications. As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team. The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market. This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company. Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial leadership, who wish to apply a fresh approach to existing markets. Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries. We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products. Click to Apply
|
|
|